can tirzepatide affect your heart In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads What to Expect Before and
Description
The move comes as both companies look to tap into a market that could be worth CNY 40 billion ($5.6 billion) by 2035
Notably, the ICER decreased with longer time horizon, suggesting improved cost-effectiveness over time
Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the apneahypopnea index, body weight, hypoxic burden, high-sensitivity C-reactive protein concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes
Diabetes 60 , 16471656 (2011)
US Address Perfect 870 Market Street, Suite 415, San Francisco, CA 94102
Of note, other weight-loss medications that are not GLP-1 receptor agonists have been associated with increased risks of psychiatric disorders or cancer
